Retirement Systems of Alabama Has $2.18 Million Stock Position in Henry Schein, Inc. (NASDAQ:HSIC)

Retirement Systems of Alabama reduced its stake in shares of Henry Schein, Inc. (NASDAQ:HSIC) by 2.5% in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 28,778 shares of the company’s stock after selling 749 shares during the quarter. Retirement Systems of Alabama’s holdings in Henry Schein were worth $2,179,000 as of its most recent filing with the SEC.

Several other institutional investors have also made changes to their positions in HSIC. Raymond James Financial Services Advisors Inc. boosted its holdings in shares of Henry Schein by 15.8% during the third quarter. Raymond James Financial Services Advisors Inc. now owns 7,057 shares of the company’s stock worth $524,000 after purchasing an additional 965 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank boosted its holdings in shares of Henry Schein by 8.1% during the third quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 23,528 shares of the company’s stock worth $1,747,000 after purchasing an additional 1,773 shares during the period. Mackenzie Financial Corp boosted its holdings in shares of Henry Schein by 0.9% during the third quarter. Mackenzie Financial Corp now owns 62,672 shares of the company’s stock worth $4,577,000 after purchasing an additional 562 shares during the period. Strs Ohio boosted its holdings in shares of Henry Schein by 13.6% during the third quarter. Strs Ohio now owns 30,886 shares of the company’s stock worth $2,293,000 after purchasing an additional 3,687 shares during the period. Finally, IFM Investors Pty Ltd boosted its holdings in shares of Henry Schein by 11.8% during the third quarter. IFM Investors Pty Ltd now owns 27,540 shares of the company’s stock worth $2,045,000 after purchasing an additional 2,914 shares during the period. 96.62% of the stock is currently owned by institutional investors and hedge funds.

Insiders Place Their Bets

In other Henry Schein news, Vice Chairman James P. Breslawski sold 2,907 shares of Henry Schein stock in a transaction on Monday, March 18th. The shares were sold at an average price of $74.37, for a total transaction of $216,193.59. Following the sale, the insider now owns 209,562 shares in the company, valued at $15,585,125.94. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. In other news, Vice Chairman James P. Breslawski sold 2,907 shares of the business’s stock in a transaction on Monday, March 18th. The shares were sold at an average price of $74.37, for a total value of $216,193.59. Following the sale, the insider now owns 209,562 shares in the company, valued at approximately $15,585,125.94. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO Bradford C. Connett sold 6,430 shares of the business’s stock in a transaction on Wednesday, March 20th. The shares were sold at an average price of $74.28, for a total transaction of $477,620.40. Following the completion of the sale, the chief executive officer now owns 73,108 shares in the company, valued at approximately $5,430,462.24. The disclosure for this sale can be found here. Corporate insiders own 1.14% of the company’s stock.

Henry Schein Trading Up 2.2 %

NASDAQ:HSIC opened at $72.76 on Thursday. Henry Schein, Inc. has a 12 month low of $60.01 and a 12 month high of $82.63. The firm has a market cap of $9.35 billion, a price-to-earnings ratio of 23.10, a P/E/G ratio of 1.68 and a beta of 0.87. The company has a quick ratio of 1.00, a current ratio of 1.67 and a debt-to-equity ratio of 0.45. The company’s 50 day moving average is $73.01 and its 200-day moving average is $72.34.

Henry Schein (NASDAQ:HSIC) last announced its earnings results on Tuesday, May 7th. The company reported $1.10 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.01 by $0.09. Henry Schein had a net margin of 3.37% and a return on equity of 14.03%. The business had revenue of $3.17 billion for the quarter, compared to analyst estimates of $3.21 billion. During the same quarter in the previous year, the firm posted $1.21 earnings per share. Henry Schein’s revenue was up 3.7% compared to the same quarter last year. Equities analysts anticipate that Henry Schein, Inc. will post 5.07 EPS for the current year.

Analysts Set New Price Targets

HSIC has been the topic of several recent research reports. Evercore ISI raised their price objective on shares of Henry Schein from $79.00 to $83.00 and gave the company an “in-line” rating in a research report on Wednesday, February 28th. TheStreet raised shares of Henry Schein from a “c+” rating to a “b-” rating in a research report on Monday, February 26th. SVB Leerink initiated coverage on shares of Henry Schein in a research report on Monday, February 26th. They set a “market perform” rating and a $78.00 price objective on the stock. Piper Sandler raised their price objective on shares of Henry Schein from $78.00 to $86.00 and gave the company an “overweight” rating in a research report on Monday, February 26th. Finally, Jefferies Financial Group raised their price objective on shares of Henry Schein from $74.00 to $81.00 and gave the company a “hold” rating in a research report on Wednesday, March 6th. One investment analyst has rated the stock with a sell rating, six have given a hold rating and five have issued a buy rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus price target of $81.73.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.